Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Structure and function of platelet receptors initiating blood clotting

Gardiner EE, Andrews RK

(2014), Adv Exp Med Biol, 844, 263-75

Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI

Gardiner EE, Andrews RK

(2014), Transfus Med Rev, 28(2), 56-60

Plasma sGPVI: Changing levels in human disease

Gardiner EE, Andrews RK

(2014), Thromb Res, 133(3), 306-7

t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions

Freeman R, Niego B, Croucher DR, Pedersen LO, Medcalf RL

(2014), Brain Res, 1565, 63-73

Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia

Fedele PL, Avery S, Patil S, Spencer A, Haas M, Wei A

(2014), Intern Med J, 44(8), 757-63

Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression

Denecker G, Vandamme N, Akay O, Koludrovic D, Taminau J, Lemeire K, Gheldof A, De Craene B, Van Gele M, Brochez L, Udupi GM, Rafferty M, Balint B, Gallagher WM, Ghanem G, Huylebroeck D, Haigh J, van den Oord J, Larue L, Davidson I, Marine JC, Berx G

(2014), Cell Death Differ, 21(8), 1250-61

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma

Campbell P, Walker P, Avery S, Patil S, Curtis D, Schwarer A, Wei A, Kalff A, Muirhead J, Spencer A

(2014), Blood Cancer J, 4, e213

Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning

Bilmon I, Nivison-Smith I, Hertzberg M, Ritchie D, Greenwood M, Spencer A, Kennedy G, Bryant A, Moore J

(2014), Bone Marrow Transplant, 49(6), 852-3

Primary haemostasis: newer insights

Berndt MC, Metharom P, Andrews RK

(2014), Haemophilia, Suppl 4, 15-22

Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase

Au AE, Sashindranath M, Borg RJ, Kleifeld O, Andrews RK, Gardiner EE, Medcalf RL, Samson AL

(2014), Cell Death Dis, 5, e1410

Post-thrombotic syndrome: A potential cause of venous ulcer

Arumugaswamy A, Tran H

(2014), Wound Pract Res, 22(2), 85-90

Lymphomania

Andrews RK, Gardiner EE

(2014), Blood, 123(20), 3057-8

Targeting GPVI as a novel antithrombotic strategy

Andrews RK, Arthur JF, Gardiner EE

(2014), J Blood Med, 5, 59-68

Neutrophil extracellular traps (NETs) and the role of platelets in infection

Andrews RK, Arthur JF, Gardiner EE

(2014), Thromb Haemost, 112(4), 659-65

Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses

Trist HM, Tan PS, Wines BD, Ramsland PA, Orlowski E, Stubbs J, Gardiner EE, Pietersz GA, Kent SJ, Stratov I, Burton DR, Hogarth PM

(2014), J Immunol, 192(2), 792-803

Optimal approach for high-risk acute promyelocytic leukemia

Iland HJ, Seymour JF, Wei A

(2014), Curr Opin Hematol, 21(2), 102-13

Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients

Govindaraj C, Tan P, Walker P, Wei A, Spencer A, Plebanski M

(2014), Clin Cancer Res, 20(3), 724-35

Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients

Govindaraj C, Madondo M, Kong YY, Tan P, Wei A, Plebanski M

(2014), Am J Hematol, 89(8), 795-802

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care

Iland HJ, Wei A, Seymour JF

(2014), Best Pract Res Clin Haematol, 27(1), 39-52

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Tan P, Wei A, Mithraprabhu S, Cummings N, Liu HB, Perugini M, Reed K, Avery S, Patil S, Walker P, Mollee P, Grigg A, D'Andrea R, Dear A, Spencer A

(2014), Blood Cancer J, 4, e170

28 29 30 31 32